<?xml version="1.0" encoding="UTF-8"?>
<ref id="B16-antibodies-09-00020">
 <label>16.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Rudenko</surname>
    <given-names>L.</given-names>
   </name>
   <name>
    <surname>Isakova-Sivak</surname>
    <given-names>I.</given-names>
   </name>
   <name>
    <surname>Naykhin</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Kiseleva</surname>
    <given-names>I.</given-names>
   </name>
   <name>
    <surname>Stukova</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Erofeeva</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Korenkov</surname>
    <given-names>D.</given-names>
   </name>
   <name>
    <surname>Matyushenko</surname>
    <given-names>V.</given-names>
   </name>
   <name>
    <surname>Sparrow</surname>
    <given-names>E.</given-names>
   </name>
   <name>
    <surname>Kieny</surname>
    <given-names>M.P.</given-names>
   </name>
  </person-group>
  <article-title>H7N9 live attenuated influenza vaccine in healthy adults: A randomised, double-blind, placebo-controlled, phase 1 trial</article-title>
  <source>Lancet Infect. Dis.</source>
  <year>2016</year>
  <volume>16</volume>
  <fpage>303</fpage>
  <lpage>310</lpage>
  <pub-id pub-id-type="doi">10.1016/S1473-3099(15)00378-3</pub-id>
  <pub-id pub-id-type="pmid">26673391</pub-id>
 </element-citation>
</ref>
